The role of the PI3K/AKT signalling pathway in the corneal epithelium: recent updates

被引:100
|
作者
Chen, Kuangqi [1 ]
Li, Yanqing [1 ]
Zhang, Xuhong [1 ]
Ullah, Rahim [2 ]
Tong, Jianping [1 ]
Shen, Ye [1 ]
机构
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Ophthalmol, Hangzhou 310003, Zhejiang, Peoples R China
[2] Zhejiang Univ, Sch Med, Childrens Hosp, Dept Endocrinol,Natl Clin Res Ctr Child Hlth, Hangzhou 310052, Zhejiang, Peoples R China
关键词
GROWTH-FACTOR RECEPTOR; OXYGEN SPECIES ROS; SUBSTANCE-P; DRY EYE; INFLAMMASOME ACTIVATION; EGFR TRANSACTIVATION; HYDROGEN-PEROXIDE; CELL-MIGRATION; MOUSE MODEL; ER STRESS;
D O I
10.1038/s41419-022-04963-x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Phosphatidylinositol 3 kinase (PI3K)/AKT (also called protein kinase B, PKB) signalling regulates various cellular processes, such as apoptosis, cell proliferation, the cell cycle, protein synthesis, glucose metabolism, and telomere activity. Corneal epithelial cells (CECs) are the outermost cells of the cornea; they maintain good optical performance and act as a physical and immune barrier. Various growth factors, including epidermal growth factor receptor (EGFR) ligands, insulin-like growth factor 1 (IGF1), neurokinin 1 (NK-1), and insulin activate the PI3K/AKT signalling pathway by binding their receptors and promote antiapoptotic, anti-inflammatory, proliferative, and migratory functions and wound healing in the corneal epithelium (CE). Reactive oxygen species (ROS) regulate apoptosis and inflammation in CECs in a concentration-dependent manner. Extreme environments induce excess ROS accumulation, inhibit PI3K/AKT, and cause apoptosis and inflammation in CECs. However, at low or moderate levels, ROS activate PI3K/AKT signalling, inhibiting apoptosis and stimulating proliferation of healthy CECs. Diabetes-associated hyperglycaemia directly inhibit PI3K/AKT signalling by increasing ROS and endoplasmic reticulum (ER) stress levels or suppressing the expression of growth factors receptors and cause diabetic keratopathy (DK) in CECs. Similarly, hyperosmolarity and ROS accumulation suppress PI3K/AKT signalling in dry eye disease (DED). However, significant overactivation of the PI3K/AKT signalling pathway, which mediates inflammation in CECs, is observed in both infectious and noninfectious keratitis. Overall, upon activation by growth factors and NK-1, PI3K/AKT signalling promotes the proliferation, migration, and anti-apoptosis of CECs, and these processes can be regulated by ROS in a concentration-dependent manner. Moreover, PI3K/AKT signalling pathway is inhibited in CECs from individuals with DK and DED, but is overactivated by keratitis.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] The role of the PI3K/AKT signalling pathway in the corneal epithelium: recent updates
    Kuangqi Chen
    Yanqing Li
    Xuhong Zhang
    Rahim Ullah
    Jianping Tong
    Ye Shen
    Cell Death & Disease, 13
  • [2] PI3K/Akt signalling pathway and cancer
    Vara, JAF
    Casado, E
    de Castro, J
    Cejas, P
    Belda-Iniesta, C
    González-Barón, M
    CANCER TREATMENT REVIEWS, 2004, 30 (02) : 193 - 204
  • [3] The Role of the PI3K/AKT/mTOR Signalling Pathway in Male Reproduction
    Deng, Chun-Yan
    Lv, Mei
    Luo, Bin-Han
    Zhao, Si-Ze
    Mo, Zhong-Cheng
    Xie, Yuan-Jie
    CURRENT MOLECULAR MEDICINE, 2021, 21 (07) : 539 - 548
  • [4] The role of PI3K/Akt signalling pathway in spinal cord injury
    Xiao, Chun-Lin
    Yin, Wen-Chao
    Zhong, Yan-Chun
    Luo, Jia-Quan
    Liu, Lu-Lin
    Liu, Wu-Yang
    Zhao, Kai
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 156
  • [5] The relation between PI3K/AKT signalling pathway and cancer
    Noorolyai, Saeed
    Shajari, Neda
    Baghbani, Elham
    Sadreddini, Sanam
    Baradaran, Behzad
    GENE, 2019, 698 : 120 - 128
  • [6] The PI3K/AKT/MTOR signaling pathway: The role of PI3K and AKT inhibitors in breast cancer
    Huemer F.
    Bartsch R.
    Gnant M.
    Current Breast Cancer Reports, 2014, 6 (2) : 59 - 70
  • [7] The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications
    Carnero, Amancio
    Blanco-Aparicio, Carmen
    Renner, Oliver
    Link, Wolfgang
    Leal, Juan F. M.
    CURRENT CANCER DRUG TARGETS, 2008, 8 (03) : 187 - 198
  • [8] Targeting the PI3K/Akt/mTOR signalling pathway in Cystic Fibrosis
    R. Reilly
    M. S. Mroz
    E. Dempsey
    K. Wynne
    S. J. Keely
    E. F. McKone
    C. Hiebel
    C. Behl
    J. A. Coppinger
    Scientific Reports, 7
  • [9] The Effect of Lycopene on the PI3K/Akt Signalling Pathway in Prostate Cancer
    Chen, Jiezhong
    O'Donoghue, Adam
    Deng, Yi-Fu
    Zhang, Bing
    Kent, Fanning
    O'Hare, Tim
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2014, 14 (06) : 800 - 805
  • [10] Targeting the PI3K/Akt/mTOR signalling pathway in Cystic Fibrosis
    Reilly, R.
    Mroz, M. S.
    Dempsey, E.
    Wynne, K.
    Keely, S. J.
    McKone, E. F.
    Hiebel, C.
    Behl, C.
    Coppinger, J. A.
    SCIENTIFIC REPORTS, 2017, 7